| Increased incidence of venous thromboembolism with cancer immunotherapy J Roopkumar, S Swaidani, AS Kim, B Thapa, L Gervaso, BP Hobbs, ... Med 2 (4), 423-434. e3, 2021 | 81 | 2021 |
| Daratumumab proves safe and highly effective in AL amyloidosis. J Khouri, A Kin, B Thapa, FJ Reu, N Bumma, CJ Samaras, HD Liu, ... British Journal of Haematology 185 (2), 2019 | 56 | 2019 |
| CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy B Thapa, PF Caimi, KM Ardeshna, M Solh, C Carlo-Stella, BS Kahl, ... Blood Advances 4 (16), 3850-3852, 2020 | 54 | 2020 |
| Physiology, NMDA receptor BE Jewett, B Thapa StatPearls [Internet], 2022 | 43 | 2022 |
| Management of brain metastases in the new era of checkpoint inhibition A Lauko, B Thapa, VA Venur, MS Ahluwalia Current neurology and neuroscience reports 18, 1-9, 2018 | 36 | 2018 |
| Venous thromboembolism in cancer patients receiving immunotherapy J Roopkumar, AS Kim, T Bicky, BP Hobbs, AA Khorana Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 29 | 2018 |
| Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI). B Thapa, J Roopkumar, AS Kim, L Gervaso, PD Patil, C Calabrese, ... Journal of Clinical Oncology 37 (15_suppl), e14151-e14151, 2019 | 24 | 2019 |
| Stem cell mobilization yields with daratumumab-and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: findings from the MASTER and … S Chhabra, N Callander, NL Watts, LJ Costa, B Thapa, JL Kaufman, ... Transplantation and Cellular Therapy 29 (3), 174. e1-174. e10, 2023 | 23 | 2023 |
| Bronchoalveolar lavage-based COVID-19 testing in patients with cancer MB Abid, S Chhabra, B Buchan, MB Graham, S Abedin, B Thapa, ... Hematology/oncology and stem cell therapy 14 (1), 65-70, 2021 | 23 | 2021 |
| The genomics of myelodysplastic syndromes: origins of disease evolution, biological pathways, and prognostic implications H Awada, B Thapa, V Visconte Cells 9 (11), 2512, 2020 | 23 | 2020 |
| PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer VS Koshkin, VG Patel, A Ali, MA Bilen, D Ravindranathan, JJ Park, ... Prostate cancer and prostatic diseases 25 (3), 388-396, 2022 | 22 | 2022 |
| Paraneoplastic syndromes B Thapa, N Mahendraker, K Ramphul | 22 | 2018 |
| A comprehensive review of the genomics of multiple myeloma: Evolutionary trajectories, gene expression profiling, and emerging therapeutics H Awada, B Thapa, H Awada, J Dong, C Gurnari, P Hari, B Dhakal Cells 10 (8), 1961, 2021 | 20 | 2021 |
| Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors A Gozzetti, A Guarnieri, E Zamagni, E Zakharova, D Coriu, M Bittrich, ... American Journal of Hematology 97 (7), 877-884, 2022 | 15 | 2022 |
| Endocrine toxicity and outcomes in patients with metastatic malignancies treated with immune checkpoint inhibitors SI Al Ashi, B Thapa, M Flores, R Ahmed, SEG Rahim, M Amir, M Alomari, ... Journal of the Endocrine Society 5 (8), bvab100, 2021 | 14 | 2021 |
| Utilization and cost implications of hematopoietic progenitor cells stored for a future salvage autologous transplantation or stem cell boost in myeloma patients S Chhabra, B Thapa, A Szabo, S Konings, A D'Souza, B Dhakal, ... Biology of Blood and Marrow Transplantation 26 (11), 2011-2017, 2020 | 13 | 2020 |
| Myeloproliferative neoplasms B Thapa, S Fazal, M Parsi, HJ Rogers | 13 | 2018 |
| Metaplastic breast cancer: characteristics and survival outcomes B Thapa, S Arobelidze, BA Clark, J Xuefei, H Daw, YC Cheng, M Patel, ... Cureus 14 (8), 2022 | 12 | 2022 |
| Cryptococcal meningitis MA Pescador Ruschel, B Thapa StatPearls. Treasure Island (FL): StatPearls Publishing, 2023 | 11 | 2023 |
| Nivolumab-Associated Guillain–Barre Syndrome in a Patient With Non–Small-Cell Lung Cancer B Thapa, S Khalid, R Vakili, J Ui, S Misbah American journal of therapeutics 25 (6), e761-e763, 2018 | 11 | 2018 |
